Seeking Alpha

  Urologix, Inc. (ULGX) - OTCQB

  • Jim Van Meerten | Send Message 31 May 2011

    ULGX - 80% Barchart technical buy signal - 16 new highs and up 21.79% in the last month - Relative Strength Index 72.63% and rising
      ULGX vs. ETF Alternatives
      Company Description
      Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from non-cancerous prostate enlargement also known as benign prostatic hyperplasia (BPH).